CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Azithromycindrug
Likely dose
Azithromycin 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01464840
NCT01464840N/ACompleted
CompareCT.gov

The Pharmacokinetics of Azithromycin Prophylaxis for Cesarean Delivery

University of Alabama at Birmingham·observational·Posted Nov 4, 2011·Updated May 11, 2017

In Brief

An observational study evaluating Azithromycin for Endometritis. Completed, enrolled 30 participants across 1 site.

Detailed Summary

PKAZ is a single institution study designed to evaluate the optimal dosing parameters for azithromycin for pre-surgical cesarean prophylaxis. Hypothesis: Pre-operative administration of azithromycin results in maternal and neonatal tissue concentrations that adequately treat microbes commonly involved in post-cesarean infections.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsEndometritis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 4, 2011
Enrollment StartNov 1, 2011
Primary CompletionMay 1, 2013
Study CompletionAug 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 14.7 years ago

Interventions

Azithromycindrug

500 mg intravenous infused over 1 hour